Press releases

Month Year

Email alerts

Nov 28, 2014

European Commission Clears Medtronic Acquisition of Covidien

MINNEAPOLIS AND DUBLIN, Ireland – Nov. 28, 2014 – Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced that the European Commission has conditionally cleared Medtronic’s...
Nov 26, 2014

Medtronic Acquisition of Covidien Receives U.S. FTC Clearance

MINNEAPOLIS AND DUBLIN, Ireland - Nov. 26, 2014 - Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced the receipt of U.S. Federal Trade Commission (FTC) clearance of...
Nov 24, 2014

Covidien’s Fortrex™ PTA Balloon Receives FDA 510(k) Clearance

Fortrex™ PTA Balloon Facilitates Arteriovenous Access in Patients Receiving Hemodialysis for Chronic Kidney Disease

DUBLIN, Ireland--(BUSINESS WIRE)--Nov. 24, 2014-- Covidien plc (NYSE: COV) today announced U.S. Food and Drug Administration 510(k) clearance for its Fortrex™ over-the-wire (OTW) percutaneous...
Nov 21, 2014

Covidien Announces Mailing of Definitive Joint Proxy Statement/Prospectus

DUBLIN, Ireland--(BUSINESS WIRE)--Nov. 21, 2014-- Covidien plc (NYSE: COV) today announced, for purposes of the Irish Takeover Rules, that the definitive joint proxy statement of Covidien plc and...
Nov 20, 2014

Covidien Achieves CE Mark for the Nellcor™ Bedside SpO2 Patient Monitoring System, PM100N

New device is the only commercially available bedside monitor designed for home care and sleep study settings

DUBLIN, Ireland--(BUSINESS WIRE)--Nov. 20, 2014-- Covidien (NYSE: COV) today announced CE Mark approval for its Nellcor™ Bedside SpO2 Patient Monitoring System, PM100N. The system currently is...

Show per page

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa